RxSight(US:RXST)2026-01-12 21:34Financial Results - On January 11, 2026, RxSight, Inc. announced preliminary unaudited financial results for Q4 and full-year 2025[6]. - The financial results announcement is not deemed "filed" under the Exchange Act[7]. - The press release is attached as Exhibit 99.1 for further details on the financial results[17]. Executive Appointment - The company appointed Mark Wilterding as Chief Financial Officer effective January 11, 2026, replacing Shelley Thunen[8]. - The press release regarding Mr. Wilterding's appointment was issued on January 11, 2026[15]. Compensation Details - Mr. Wilterding's annual base salary is set at $550,000, with an annual bonus potential of up to 65% of his base salary[10]. - Mr. Wilterding received options to purchase 258,770 shares of common stock and an award of 163,528 restricted stock units[11]. Company Classification - The company is not classified as an emerging growth company under the Securities Act[5]. - The company operates under the Nasdaq Stock Market LLC with the symbol RXST[5]. - The company is expected to file the full text of the Employment Agreement and Severance Agreement in a subsequent periodic report[14].